Scientists from the Institute of Medical Biology (IMB) and Bioprocessing Technology Institute (BTI), under Singapore’s Agency for Science, Technology and Research (A*STAR), and the University Medical Center Utrecht in the Netherlands have jointly developed a novel way to improve survival and recovery rate after a heart attack. This method, the first non-cell based therapeutic application of human embryonic stem cells (hESCs), entails using secretions from stem cells.
Said Dr Lim Sai Kiang, IMB, who leads the group from Singapore, “Using secretion instead of cells allows us to circumvent many highly intractable problems such as tumour formation, immune compatibility, cell viability, delivery, costs and timeliness.” Unlike the more common approach of directly administering stem cells for therapy, this new method carries negligible risk of tumour formation or rejection by the body.
The scientists discovered that this approach could minimise heart injury after a heart attack. This is particularly important as the heart has a limited ability to regenerate. The preclinical work was carried out on pigs, the closest animal approximation to the human heart in terms of size, structure and function, and the findings were published in science journal Stem Cell Research. The research findings are especially important as they show that the new method can overcome the unwanted side effects of reperfusion— the best therapeutic option currently available to heart attack patients.
Reperfusion is the restoration of blood flow to the oxygen-deprived heart after a heart attack. Heart attack or Myocardial Infarction (MI) occurs when blood flow to part of the heart is blocked and the heart muscle is deprived of oxygen. If allowed to persist, prolonged oxygen deprivation causes cell death and irreversible loss of heart function, and inevitably progresses to heart failure and death. To minimise heart muscle damage and preserve the pumping action of the heart after MI occurs, early reperfusion by standard medical treatments such as angioplasty (commonly known as “ballooning”) or bypass surgery is carried out in the hospital. Despite this, most MI patients suffer additional irreversible cardiac muscle cell loss, ironically as a result of these treatments— a condition known as reperfusion injury.
The researchers found that the administration of secretion from stem cells minimised heart injury by enhancing reperfusion therapy and reducing tissue death by another 60%. Heart function was also markedly improved. By demonstrating the efficacy of this secretion in an experimental pig model, currently the best approximation to a human heart attack patient undergoing reperfusion therapy, the researchers have addressed the longstanding problem of reperfusion injury in the most clinically relevant experimental setting.
Said the advisor to the team of researchers in Singapore, Professor Lee Chuen-Neng, who is the Head of the Department of Cardiac, Thoracic and Vascular Surgery at the National University Hospital, Singapore and Chair of Surgery at the National University Health System, Singapore, “This is a major discovery of clinical significance. There are some problems and issues associated with the use of stem cells to treat heart attacks and blocked arteries in the heart, and with this new method, many of these issues are removed. Potentially, we may have an important way to treat heart attacks. More tests will need to be done and human trials planned.”
This discovery is all the more significant because the therapy for reperfusion injury remains an unmet need despite three decades of huge resource investment, thousands of research papers and hundreds of experimental protocols. This preclinical study had come amidst an international call to improve the translation of preclinical experimental therapies for reperfusion injury to clinical applications.
As Singapore moves from basic science towards translational studies in the next phase of its biomedical push, rigorous preclinical testing and carefully designed studies such as this would be most critical in ensuring the success of clinical trials. Professor Birgit Lane, who is Executive Director of the IMB said, “This is a very exciting result from Dr Lim and her colleagues.
It paves the way for improved recovery after heart attack - a very practical outcome from stem cell research. It is a great example of what can be achieved when doctors and scientists work closely together. By sharing their specialist skills and knowledge, they can discover and refine new approaches to curing sick people. This targeting of research to find ways of combating illness and benefiting people faster is at the heart of what we aim to do at IMB.”
Joshua Woo | alfa
New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences
The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
21.11.2017 | Physics and Astronomy
21.11.2017 | Physics and Astronomy
21.11.2017 | Life Sciences